Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Mercury General | MCY | 15. oct 2024 | 66.15 | +0.55 |
Mercury Systems | MRCY | 15. oct 2024 | 35.99 | +0.39 |
Mereo BioPharma ADR | MREO | 15. oct 2024 | 4.54 | +1.57 |
Meridian | MRBK | 15. oct 2024 | 12.95 | +0.78 |
MeridianLink | MLNK | 15. oct 2024 | 21.14 | +1.05 |
Merit Medical Systems | MMSI | 15. oct 2024 | 95.67 | +0.16 |
Meritage Homes | MTH | 15. oct 2024 | 197.82 | +0.55 |
Merrill Lynch & Co. | IPB | 15. oct 2024 | 26.45 | -0.16 |
Mersana Therapeutics | MRSN | 15. oct 2024 | 2.13 | +3.40 |
Merus N.V | MRUS | 15. oct 2024 | 51.35 | -1.57 |
Mesa Air Group | MESA | 15. oct 2024 | 1.16 | -1.69 |
Mesa Laboratories | MLAB | 15. oct 2024 | 130.95 | +1.87 |
Mesa Royalty Trust | MTR | 15. oct 2024 | 6.02 | -1.63 |
Mesabi Royalty Trust | MSB | 15. oct 2024 | 25.57 | +2.12 |
Mesoblast ADR | MESO | 15. oct 2024 | 9.62 | -3.12 |
Meta Materials | MMAT | 15. oct 2024 | 0.64 | 0.00 |
Meta Platforms A | META | 15. oct 2024 | 586.27 | -0.70 |
Metagenomi | MGX | 15. oct 2024 | 1.97 | +1.03 |
Metal Sky Star Acquisition | MSSA | 15. oct 2024 | 11.58 | +1.05 |
Metalla Royalty & Streaming | MTA | 15. oct 2024 | 3.60 | +2.27 |
Metallus | MTUS | 15. oct 2024 | 14.23 | -3.00 |
Metals Acquisition | MTAL | 15. oct 2024 | 12.59 | -1.41 |
Methalpa Technology Holding | MATH | 15. oct 2024 | 1.19 | -1.64 |
Methanex | MEOH | 15. oct 2024 | 40.89 | -2.22 |
Methode Electronics | MEI | 15. oct 2024 | 10.99 | -1.17 |
MetLife | MET | 15. oct 2024 | 85.66 | -0.26 |
Metlife Pref A | MET-A | 15. oct 2024 | 24.51 | +0.29 |
Metlife Pref E | MET-E | 15. oct 2024 | 25.10 | +0.24 |
Metlife Pref F | MET-F | 15. oct 2024 | 22.97 | +0.39 |
MetroCity Bankshares | MCBS | 15. oct 2024 | 31.03 | +1.27 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.